Olaf Penack
Impact in
- Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Oncology top 2%
- Neutropenia and Cancer Infections
- CAR-T cell therapy research
Papers in
- Hematology 64
- Hematopoietic Stem Cell Transplantation 54
- Acute Myeloid Leukemia Research 12
- Oncology 60
- CAR-T cell therapy research 26
- Neutropenia and Cancer Infections 22
- Co-authors
- Dieter Buchheidt (17 shared papers)Marcel R.M. van den Brink (9 shared papers)Ernst Holler (3 shared papers)Georg Maschmeyer (15 shared papers)Oliver A. Cornely (12 shared papers)Markus Ruhnke (11 shared papers)Martin Schmidt‐Hieber (8 shared papers)Meinolf Karthaus (10 shared papers)
- Journals
- Blood (23 papers)Annals of Hematology (15 papers)Bone Marrow Transplantation (13 papers)Frontiers in Immunology (11 papers)Annals of Oncology (10 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Olaf Penack
131 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 112
- Hematology 1.2k
- Oncology 1.5k
- Infectious Diseases 944
- Immunology 953
- Transplantation 102
Countries citing papers authored by Olaf Penack
This map shows the geographic impact of Olaf Penack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Penack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Penack more than expected).
Fields of papers citing papers by Olaf Penack
This network shows the impact of papers produced by Olaf Penack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Penack. The network helps show where Olaf Penack may publish in the future.
Co-authors
The 25 scholars most cited alongside Olaf Penack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 136 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 137 | |
| 2 | 2016 | 133 | |
| 3 | 2013 | 121 | |
| 4 | 2009 | 118 | |
| 5 | 2017 | 115 | |
| 6 | 2005 | 112 | |
| 7 | 2020 | 105 | |
| 8 | 2020 | 102 | |
| 9 | 2019 | 100 | |
| 10 | 2017 | 100 | |
| 11 | 2022 | 91 | |
| 12 | 2008 | 90 | |
| 13 | 2019 | 89 | |
| 14 | 2009 | 84 | |
| 15 | 2011 | 84 | |
| 16 | 2011 | 83 | |
| 17 | 2006 | 83 | |
| 18 | 2020 | 78 | |
| 19 | 2006 | 72 | |
| 20 | 2022 | 70 |
About Olaf Penack
Olaf Penack is a scholar working on Hematology, Oncology, Immunology, Epidemiology and Infectious Diseases, having authored 136 papers that have together received 3.9k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (54 papers), CAR-T cell therapy research (26 papers), Neutropenia and Cancer Infections (22 papers), Immune Cell Function and Interaction (20 papers), Antifungal resistance and susceptibility (20 papers), Fungal Infections and Studies (17 papers), T-cell and B-cell Immunology (16 papers) and Acute Myeloid Leukemia Research (12 papers). The work is most often cited by research in Hematology (1.2k citations), Oncology (1.5k citations), Infectious Diseases (944 citations), Immunology (953 citations) and Transplantation (102 citations). Olaf Penack has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Dieter Buchheidt, Marcel R.M. van den Brink, Ernst Holler, Georg Maschmeyer, Oliver A. Cornely, Markus Ruhnke, Martin Schmidt‐Hieber, Meinolf Karthaus, Silke Neumann and Andrew J. Ullmann. Their work appears in journals such as Blood, Annals of Hematology, Bone Marrow Transplantation, Frontiers in Immunology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.